2,508
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Factors associated with increase in blood pressure and incident hypertension in early midlife: the Hordaland Health Study

, , , , &
Pages 267-275 | Received 06 Feb 2020, Accepted 19 Apr 2020, Published online: 13 May 2020

References

  • WHO [Internet]. Geneva (Switzerland): World Health Organization. Hypertension; 2019 [cited 2020 January 03]. Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension.
  • Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001;358(9294):1682–1686.
  • de Simone G, Devereux RB, Chinali M, et al. Risk factors for arterial hypertension in adults with initial optimal blood pressure: the Strong Heart Study. Hypertension. 2006;47(2):162–167.
  • Wilsgaard T, Schirmer H, Arnesen E. Impact of body weight on blood pressure with a focus on sex differences: the Tromso Study, 1986–1995. Arch Intern Med. 2000;160(18):2847–2853.
  • Fryar CD, Ostchega Y, Hales CM, et al. Hypertension prevalence and control among adults: United States, 2015. NCHS Data Brief. 2016;2017(289):1–8.
  • Scuteri A, Morrell CH, Orru M, et al. Longitudinal perspective on the conundrum of central arterial stiffness, blood pressure, and aging. Hypertension. 2014;64(6):1219–1227.
  • Hasselstrom J, Zarrinkoub R, Holmquist C, et al. The Swedish primary care cardiovascular database (SPCCD): 74 751 hypertensive primary care patients. Blood Press. 2014;23(2):116–125.
  • Wallentin F, Wettermark B, Kahan T. Current antihypertensive drug therapy in 12,436 Swedish patients, 90 years and above, in relation to sex and comorbidity. Blood Press. 2019;26:1–7.
  • Refsum H, Nurk E, Smith AD, et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr. 2006;136(6):1731S–1740S.
  • Nygård O, Vollset S, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study. JAMA. 1995;274(19):1526–1533.
  • Williams B, Mancia G, Spiering W, et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Pressure. 2018;27(6):314–340.
  • WHO [Internet]. Geneva (Switzerland): World Health Organization. Obesity and overweight; 2018 [updated 16 February 2018; cited 2019 May 13th]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
  • Sharabi Y, Grotto I, Huerta M, et al. Susceptibility of the influence of weight on blood pressure in men versus women: lessons from a large-scale study of young adults. Am J Hypertens. 2004;17(5):404–408.
  • Fujita M, Hata A. Sex and age differences in the effect of obesity on incidence of hypertension in the Japanese population: a large historical cohort study. J Am Soc Hypertens. 2014;8(1):64–70.
  • Liu K, Ruth KJ, Flack JM, et al. Blood pressure in young blacks and whites: relevance of obesity and lifestyle factors in determining differences. The CARDIA Study. Coronary Artery Risk Development in Young Adults. Circulation. 1996;93(1):60–66.
  • Grassi G, Vailati S, Bertinieri G, et al. Heart rate as marker of sympathetic activity. J Hypertens. 1998;16(11):1635–1639.
  • Wang A, Liu X, Guo X, et al. Resting heart rate and risk of hypertension: results of the Kailuan cohort study. J Hypertens. 2014;32(8):1600–1605.
  • Laaksonen DE, Niskanen L, Nyyssonen K, et al. Dyslipidaemia as a predictor of hypertension in middle-aged men. Eur Heart J. 2008;29(20):2561–2568.
  • Zachariah JP, Rong J, Larson MG, et al. Metabolic predictors of change in vascular function: prospective associations from a community-based cohort. Hypertension. 2018;71(2):237–242.
  • Hansen SEJ, Madsen CM, Varbo A, et al. Low-grade inflammation in the association between mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis: a study of more than 115000 individuals from the general population. Clin Chem. 2019;65(2):321–332.
  • Egeland GM, Igland J, Sulo G, et al. Non-fasting triglycerides predict incident acute myocardial infarction among those with favourable HDL-cholesterol: Cohort Norway. Eur J Prev Cardiolog. 2015;22(7):872–881.
  • Preis SR, Pencina MJ, Mann DM, et al. Early-adulthood cardiovascular disease risk factor profiles among individuals with and without diabetes in the Framingham Heart Study. Diabetes Care. 2013;36(6):1590–1596.
  • Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014;57(8):1542–1551.
  • Sesso HD, Buring JE, Chown MJ, et al. A prospective study of plasma lipid levels and hypertension in women. Arch Intern Med. 2005;165(20):2420–2427.
  • Halperin RO, Sesso HD, Ma J, et al. Dyslipidemia and the risk of incident hypertension in men. Hypertension. 2006;47(1):45–50.
  • Otsuka T, Takada H, Nishiyama Y, et al. Dyslipidemia and the risk of developing hypertension in a working-age male population. J Am Heart Assoc. 2016;5(3):e003053.
  • Banach M, Nikfar S, Rahimi R, et al. The effects of statins on blood pressure in normotensive or hypertensive subjects–a meta-analysis of randomized controlled trials. Int J Cardiol. 2013;168(3):2816–2824.
  • Bansal S, Buring JE, Rifai N, et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298(3):309–316.
  • Nordestgaard BG, Benn M, Schnohr P, et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299–308.